Anna Degen, PhD, currently serves as Site Manager and Commercial Lead (Discovery and Mapping) at Biosynth, a position held since September 2024. Prior roles at Biosynth include Business Line Manager for Neoantigens & Peptide Drug Discovery and Product Specialist for Personalized Peptides, where responsibilities involved cultivating partnerships, overseeing project milestones, negotiating contracts, and collaborating on regulatory matters. Anna Degen contributed to research as a Postdoctoral Researcher and PhD Researcher at the DKFZ German Cancer Research Center, focusing on synthetic biology. Educational qualifications include a PhD in Synthetic Biology from DKFZ, a Master's Degree in Molecular Biotechnology from Heidelberg University, and a Bachelor's Degree in the same field. Anna Degen's foundational experiences span various internships and roles across reputable institutions, emphasizing a strong background in molecular biotechnology and project management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices